About Daniel Wengelin

Daniel Wengelin is an associate based in Magnusson’s office in Stockholm and the newest addition to Magnusson Sweden’s life sciences team. Daniel focuses his practice on life sciences as well as competition and public procurement. Daniel is assisting clients in the life sciences industry with regulatory issues, including questions related to substitution, as well as administrative court proceedings, including appealing decisions by relevant authorities. Daniel worked as a case officer at the Swedish Competition Authority before joining Magnusson in 2024.

Contributions to Global Practice Guide

Pharmaceutical Advertising Law and Practice in Sweden

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.